Lumibird S.A (LBIRD) | Stock Overview & Key Data
Lumibird S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €27.65 on May 29, 2026
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Lumibird S.A
LBIRD
|
540.61M Mid-cap | -3.69% | 0.00% | 15.76% | 15.76% | 15.76% | 19.40% | 19.40% | 19.40% | 19.40% | 19.40% | 19.40% |
| 10.82B Large-cap | -2.31% | 6.92% | 3.43% | 8.79% | 2.23% | 6.23% | 4.20% | -30.63% | -80.05% | -29.49% | -29.49% | |
|
bioMérieux S.A
BIM
|
8.37B Large-cap | -6.77% | -5.86% | -28.78% | -37.02% | -38.40% | -43.82% | -26.63% | -26.39% | 78.29% | 224.16% | 224.16% |
|
Eurofins Cerep SAS
ALECR
|
79.70M Small-cap | -11.56% | -3.77% | -15.00% | -8.93% | -14.04% | -25.73% | -47.24% | 13.33% | 205.88% | 512.00% | 512.00% |
|
Klea Holding
ALKLH
|
53.98M Small-cap | 5.56% | -5.00% | 5.56% | -17.39% | -13.64% | -5.26% | -5.26% | -5.26% | -5.26% | -5.26% | -5.26% |
|
Predilife S.A
ALPRE
|
12.22M Small-cap | 6.56% | -9.72% | -18.75% | -17.20% | -17.98% | -29.54% | -55.17% | -60.31% | -72.04% | -72.04% | -72.04% |
Ownership & Short Interest
Calculate Your Lumibird S.A Investment Returns
Long-Term Investment Performance Analysis
Lumibird S.A stock price in Mar 2026 was €20.10, A €1,000.00 lump sum investment in Lumibird S.A made 0 years ago would be worth approximately €1,169.15 today, representing a positive return of 16.92%.
2 Months Investment Scenario (Mar 2026 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is LBIRD's 52-week high and low?
- In the last 52 weeks, Lumibird S.A reached a high of €27.65 (on May 29, 2026) and a low of €13.90 (on N/A).
- What is the market cap and P/E ratio for LBIRD?
- Curious about Lumibird S.A's size and valuation? Its market capitalization stands at 540.61M. When it comes to valuation, the P/E ratio (trailing twelve months) is 38.59, and the forward P/E (looking ahead) is 20.84.
- Does LBIRD pay dividends? If so, what's the yield?
- As for dividends, Lumibird S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Lumibird S.A's main competitors or similar companies to consider before investing?
When looking at Lumibird S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Eurofins Scientific
ERF10.82B Healthcare Diagnostics & Research 6.23% 4.20% bioMérieux S.A
BIM8.37B Healthcare Diagnostics & Research -43.82% -26.63% Eurofins Cerep SAS
ALECR79.70M Healthcare Diagnostics & Research -25.73% -47.24% Klea Holding
ALKLH53.98M Healthcare Diagnostics & Research -5.26% -5.26% Predilife S.A
ALPRE12.22M Healthcare Diagnostics & Research -29.54% -55.17% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Lumibird S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Lumibird S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.93%, the Debt to Equity ratio from the most recent quarter is 70.86, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for LBIRD?
- Looking at Lumibird S.A's growth, its revenue over the trailing twelve months (TTM) was €229M. Compared to the same quarter last year (YoY), quarterly revenue grew by 8.50%, and quarterly earnings saw a YoY growth of 56.40%.
- How much of LBIRD stock is held by insiders and institutions?
- Wondering who owns Lumibird S.A stock? Company insiders (like executives and directors) hold about 53.58% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 17.65%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.